InChI=1S/C22H34O4/c1- 2- 3- 4- 5- 6- 7- 10- 15- 20(23) 16- 11- 8- 12- 17- 21(24) 18- 13- 9- 14- 19- 22(25) 26/h3- 4,6- 8,10- 12,15,17,20- 21,23- 24H,2,5,9,13- 14,16,18- 19H2,1H3,(H,25,26) /b4- 3- ,7- 6- ,11- 8- ,15- 10+,17- 12+ |
BCWQNTXSYCKTHB-QIDYMIIRSA-N |
CC/C=C\C\C=C/C=C/C(C\C=C/C=C/C(CCCCCC(=O)O)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
specialised pro-resolving mediator
A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation.
(via resolvin )
|
|
View more via ChEBI Ontology
(8E,10Z,14E,16Z,19Z)- 7,13- dihydroxydocosa- 8,10,14,16,19- pentaenoic acid
|
(8E,10Z,14E,16Z,19Z)-7,13-dihydroxydocosapentaenoic acid
|
ChEBI
|
13-series resolvin 4
|
ChEBI
|
RvT4
|
ChEBI
|
26236990
|
PubMed citation
|
Europe PMC
|
27704804
|
PubMed citation
|
Europe PMC
|
|